Skip to main content

Table 1 Characteristics of the study population at inclusion in the WADANUT study, 2014-2016, N=326

From: Assessment of dietary diversity and nutritional support for children living with HIV in the IeDEA pediatric West African cohort: a non-comparative, feasibility study

Inclusion characteristics Total
N=326
Benin
N=91
Côte d’Ivoire
N=158
Togo
N=77
p-value*
N % N % N % N %
Socio-demographic data
Age at inclusion          0.415
  0-2yrs 27 8.3 11 12.1 13 8.2 3 3.9  
  2-5yrs 84 25.8 24 26.4 39 24.7 21 27.3  
  5-10yrs 215 66.0 56 61.5 106 67.1 53 68.8  
Sex          0.593
  Males 170 52.1 46 50.5 87 55.1 38 49.4  
  Females 156 47.9 45 49.5 71 44.9 39 50.6  
Primary caregiver          0.001
  Father, mother 269 82.5 79 86.8 118 74.7 72 93.5  
  Other family member 47 14.4 12 13.2 31 19.6 4 5.2  
  Other (institute or missing) 10 3.1 0 0.0 9 5.7 1 1.3  
Orphanhood          0.570
  Non orphan 236 72.4 66 72.5 111 70.3 59 76.6  
  One parent 84 25.8 22 24.2 44 27.8 18 23.4  
  Two parents 6 1.8 3 3.3 3 1.9 0 0.0  
Treatments
On antiretroviral therapy 298 91.4 79 86.8 142 89.9 77 100.0 0.001
  Based on PIs 61 20.5 18 22.8 26 18.3 17 22.1 0.294
  Based on NRTIs 228 76.5 61 77.2 111 78.2 56 72.7  
  Missing data 9 3.0 0 0.0 5 3.5 4 5.2  
Duration on ART          0.018
  0-2 yrs 120 40.3 37 40.7 65 45.8 18 23.4  
  2-5 yrs 105 35.2 25 27.5 44 31.0 36 46.8  
  5-10yrs 71 23.8 17 18.7 33 23.2 21 27.3  
  Missing data 2 0.7 0 0.0 0 0.0 2 2.6  
On Cotrimoxazole prophylaxis 242 74.2 72 79.1 146 92.4 77 100.0 <0.001
Clinical status and co-morbidities
Immunodeficiency for agea
  No 176 54.0 36 39.6 97 61.4 43 55.8 <0.001
  Moderate 39 12.0 6 6.6 25 15.8 8 10.4  
  Severe 55 16.9 16 17.6 33 20.9 6 7.8  
  Missing data 56 17.2 33 36.3 3 1.9 20 26.0  
WHO stage
  I-II 214 65.6 79 86.8 61 38.6 74 96.1 <0.001
  III-IV 86 26.4 11 12.1 73 46.2 2 2.6  
  Missing data 26 8.0 1 1.1 24 15.2 1 1.3  
Viral load          <0.001
  <500 52 16.0 37 40.7 16 10.1 0 0.0  
  >500 78 23.9 36 39.6 41 25.9 0 0.0  
  Missing data 196 60.1 18 19.8 101 63.9 77 100.0  
Opportunistic infections
during the last 6 months
  Tuberculosis 8 2.5 2 2.2 6 3.8 0 0.0 0.262
  Pneumonia 23 7.1 10 11.0 8 5.1 5 6.5 0.208
  Malaria 47 14.4 6 6.6 9 5.7 32 41.6 <0.001
  Diarrhoea 17 5.2 4 4.4 9 5.7 4 5.2 0.948
  Other (?) 17 5.2 4 4.4 15 9.5 34 44.2 <0.001
Malnutritionb
Underweight (Weight-for-age)          0.128
  No 245 75.2 65 71.4 115 72.8 65 84.4  
  Moderate 55 16.9 15 16.5 30 19.0 10 13.0  
  Severe 26 8.0 11 12.1 13 8.2 2 2.6  
Wasting (Weight-for-Height, BMI for age)          0.170
  No 292 89.6 82 90.1 135 85.4 75 97.4  
  Moderate 25 7.7 7 7.7 17 10.8 1 1.3  
  Severe 9 2.8 2 2.2 6 3.8 1 1.3  
Stunting (Height-for-age)          0.376
  No 232 71.2 62 68.1 118 74.7 52 67.5  
  Moderate 62 19.0 16 17.6 28 17.7 18 23.4  
  Severe 32 9.8 13 14.3 12 7.6 7 9.1  
  1. ART antiretroviral therapy, PIs Protease Inhibitors, NRTIs Nucleoside Reverse Transcriptase Inhibitors, WHO World Health Organization
  2. * Chi-square or Fisher’s exact test
  3. a WHO guidelines 2006
  4. b Severe malnutrition: Z-score<-3SD, moderate malnutrition: Z-score=[-3;-2[ SD